No Data
No Data
Replimune Group Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $18
Replimune Price Target Raised to $18 From $16 at JPMorgan
Express News | Watching Replimune Group; Shares See A Small Pop In Volume, Hearing Popular Retail Trading Newsletter Picks Stock
Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Leerink Partners Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $21